Cargando…
The value of serology testing to manage SARS-CoV-2 infections
Validated serology tests are a good complement for the SARS-CoV-2 RNA test, allow rapid epidemiological control and reveal immune status before and after vaccination. https://bit.ly/3eKAc6h
Autores principales: | Fernández-Barat, Laia, López-Aladid, Ruben, Torres, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366174/ https://www.ncbi.nlm.nih.gov/pubmed/32675201 http://dx.doi.org/10.1183/13993003.02411-2020 |
Ejemplares similares
-
Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome
por: Fernández-Barat, Laia, et al.
Publicado: (2020) -
Serology Testing for SARS-CoV-2: Benefits and Challenges
por: Jalali Nadoushan, Mohammadreza, et al.
Publicado: (2020) -
SARS-CoV-2–induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas-Exchange Abnormalities
por: Barbeta, Enric, et al.
Publicado: (2020) -
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
por: Dobaño, Carlota, et al.
Publicado: (2021) -
Serological Tests in the Detection of SARS-CoV-2 Antibodies
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2021)